Cart
sales@molnova.com
Mal-PEG4-NHS ester
CAS No. 1325208-25-0
Mal-PEG4-NHS ester( —— )
Catalog No. M33425 CAS No. 1325208-25-0
Mal-PEG4-NHS ester is a noncleavable ADC linker with a Maleimide group, a 4-unit PEG, and an NHS ester.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 34 | Get Quote |
|
| 10MG | 49 | Get Quote |
|
| 25MG | 76 | Get Quote |
|
| 50MG | 113 | Get Quote |
|
| 100MG | 170 | Get Quote |
|
| 500MG | 381 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMal-PEG4-NHS ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionMal-PEG4-NHS ester is a noncleavable ADC linker with a Maleimide group, a 4-unit PEG, and an NHS ester.
-
DescriptionMal-PEG4-NHS ester is a non-cleavable ADC linker which links Quantum dots (QDs) with PEGylated liposomes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetADCs Linker/Click Chemistry
-
RecptorADC Linker
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1325208-25-0
-
Formula Weight442.42
-
Molecular FormulaC19H26N2O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (226.03 mM; Ultrasonic )
-
SMILESO=C(ON1C(=O)CCC1=O)CCOCCOCCOCCOCCN2C(=O)C=CC2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mukthavaram R, et al. Assembly and targeting of liposomal nanoparticles encapsulating quantum dots. Bioconjug Chem. 2011;22(8):1638-1644.?
molnova catalog
related products
-
Fmoc-8-amino-3,6-dio...
Fmoc-8-amino-3,6-dioxaoctanoic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
-
Amino-PEG8-Boc
Amino-PEG8-Boc is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG8-Boc is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DSP Crosslinker
DSP Crosslinker is a cleavable ADC linker, used in the synthesis of antibody-drug conjugates (ADCs).
